Topics: Challenging Real Life Psoriasis Cases Faculty: Ted Rosen, MD From the SDPA Annual Summer Dermatology Conference 2017. Learning Objectives: 1. Attendee will be presented with selected psoriasis cases drawn from the presenter’s patient population 2. Attendee will be asked to identify the challenging aspect of the case, mimicking what might […]
March 19, 2019
From the SDPA Annual Summer Dermatology Conference 2018, held June 27 – July 1, 2018 in Seattle, Washington. Topic: How I Treat Hidradenitis in 2018 Faculty: Joslyn Kirby, MD Learning Objectives: 1. Review stage- and guideline-based treatment of HS 2. Review new and established medical therapies for HS 3. Describe office-based […]
March 13, 2019
Topics: Dupixent (dupilumab) Injection – The First Biologic for Adults with Controlled Moderate-to-Severe Atopic Dermatitis Faculty: Andrew Blauvelt, MD, MBA This Product Theater, sponsored by Regeneron Pharmaceuticals / Sonofi Genzyme, is from the SDPA Annual Summer Dermatology Conference 2017.
March 12, 2019
From the SDPA Annual Summer Dermatology Conference 2018, held June 27 – July 1, 2018 in Seattle, Washington. Topic: Comorbidities in Hidradenitis: Fact or Fiction? Faculty: Joslyn Kirby, MD Learning Objectives: 1. Describe the academic and professional impact of HS on people 2. Discuss the emotional and spiritual impact of HS […]
March 6, 2019
Topics: Tropical Souvenirs: Bugs, Bites and Parasites Faculty: Ted Rosen, MD From the SDPA Annual Summer Dermatology Conference 2017. Learning Objectives: 1. Attendee will understand the current epidemiology of infectious diseases acquired in the tropics, concentrating on cutaneous disorders 2. Attendee will be able to make tentative diagnosis of cutaneous disorders […]
March 5, 2019
Topics: What’s New in BCC and SCCA Faculty: Roger Ceilley, MD From the SDPA Annual Summer Dermatology Conference 2017. Learning Objectives: 1. Understanding new developments in basal cell carcinoma 2. Understand new developments and risk factors in squamous cell carcinoma 3. Understanding new treatments for BCC 4. Understanding high risk […]
February 26, 2019